PROF
Profound Medical Corp.
$6.92
+$0.19(+2.82%)
57
Overall
80
Value
60
Tech
31
Quality
Market Cap
$244.38M
Volume
66.56K
52W Range
$3.76 - $8.95
Target Price
$11.13
Order:
Income Statement
| Metric | Trend | Chart | 2016 Dec | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec | 2025 Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||
| Total Revenue | -- | $4.9M | $2.6M | $4.2M | $7.3M | $6.9M | $6.7M | $7.2M | $10.7M | $16.1M | ||
| Total Revenue | -- | $4.9M | $2.6M | $4.2M | $7.3M | $6.9M | $6.7M | $7.2M | $10.7M | $16.1M | ||
| COST OF GOODS SOLD | ||||||||||||
| Cost of Revenue | -- | $3.0M | $1.8M | $1.3M | $3.8M | $3.9M | $3.7M | $2.9M | $3.6M | $4.7M | ||
| GROSS PROFIT | ||||||||||||
| Gross Profit | -- | $1.9M | $823.8K | $2.9M | $3.5M | $3.0M | $3.0M | $4.3M | $7.0M | $11.4M | ||
| OPERATING EXPENSES | ||||||||||||
| Operating Expenses | $11.6M | $19.5M | $21.0M | $19.8M | $22.3M | $33.2M | $32.6M | $33.0M | $40.1M | $52.6M | ||
| Research & Development | $7.4M | $9.6M | -- | $2.2M | $9.9M | $15.3M | $14.7M | $14.4M | $17.0M | $20.6M | ||
| Research Expense | -- | $9.6M | -- | $2.2M | -- | -- | $14.7M | $14.4M | $17.0M | $20.6M | ||
| Selling, General & Administrative | $4.2M | $9.9M | $21.0M | $7.6M | $12.4M | $18.0M | $17.9M | $18.5M | $23.1M | $32.1M | ||
| Selling & Marketing Expenses | $954.1K | $3.9M | $4.1M | $2.1M | $4.9M | $7.7M | $8.5M | $9.5M | -- | -- | ||
| General & Administrative Expenses | $3.3M | $5.9M | $16.9M | $5.5M | $7.6M | $10.3M | $9.5M | $18.5M | $23.1M | $32.1M | ||
| Salaries & Wages | -- | -- | -- | $8.5M | -- | -- | -- | -- | -- | -- | ||
| Depreciation & Amortization | -- | -- | -- | $1.5M | -- | -- | $-290.0K | -- | -- | -- | ||
| Depreciation & Amortization | -- | -- | -- | $1.5M | -- | -- | $-290.0K | -- | -- | -- | ||
| Amortization | -- | -- | -- | -- | -- | -- | $-290.0K | -- | -- | -- | ||
| Other Operating Expenses | $1.6K | -- | -- | -- | -- | -- | $-3.1M | $575.0K | -- | -- | ||
| OPERATING INCOME | ||||||||||||
| Operating income | $-11.6M | -- | -- | $-16.9M | $-18.9M | $-30.3M | $-29.6M | $-28.7M | $-33.1M | $-41.3M | ||
| EBITDA | $-11.4M | $-16.6M | $-18.0M | $-15.4M | $-19.5M | $-28.6M | $-26.6M | $-26.4M | $-34.5M | $-41.8M | ||
| NON-OPERATING ITEMS | ||||||||||||
| Interest Expense (Non-Operating) | $615.9K | $2.4M | $826.3K | $171.0K | $543.0K | $67.0K | $174.0K | $770.0K | -- | -- | ||
| Intinc | $117.3K | $127.7K | $483.8K | -- | $692.0K | $205.0K | $803.0K | $1.6M | -- | -- | ||
| Net Non-Operating Interest Income/Expense | $498.6K | $-2.2M | $-342.5K | $-171.0K | $-149.0K | $310.0K | $-919.0K | $-726.0K | -- | -- | ||
| Gain on Sale of Securities | -- | -- | -- | -- | $-2.8M | $7.0K | -- | $775.0K | $1.4M | $1.1M | ||
| Other Income/Expense | -- | -- | -- | -- | $-2.9M | $7.0K | $301.0K | $-775.0K | $-1.4M | $-1.1M | ||
| Other Special Charges | -- | -- | -- | -- | -- | -- | $290.0K | $-146.0K | -- | -- | ||
| SPECIAL ITEMS | ||||||||||||
| Restructring And Mn A Income | -- | -- | -- | -- | $90.0K | -- | -- | -- | -- | -- | ||
| Special Income Charges | -- | -- | -- | -- | $90.0K | -- | $-2.5M | -- | -- | -- | ||
| Impairment of Capital Assets | -- | -- | -- | -- | -- | -- | $2.5M | -- | -- | -- | ||
| PRE-TAX INCOME | ||||||||||||
| EBIT | $-11.5M | $-17.5M | $-19.7M | $-16.9M | $-21.0M | $-30.5M | $-28.2M | $-27.3M | $-35.4M | $-42.3M | ||
| Pre-Tax Income | $-12.1M | $-19.9M | $-20.5M | $-17.1M | $-21.6M | $-30.6M | $-28.4M | $-27.3M | $-35.4M | $-42.3M | ||
| INCOME TAX | ||||||||||||
| Tax Provision | $10.5K | $74.1K | $230.8K | $147.0K | $45.0K | $105.0K | $287.0K | $-128.0K | $290.0K | $252.0K | ||
| NET INCOME | ||||||||||||
| Net Income | $-12.1M | $-19.9M | $-20.8M | $-17.2M | $-21.6M | $-30.7M | $-28.7M | $-27.2M | $-35.7M | $-42.6M | ||
| Net Income (Continuing Operations) | $-12.1M | -- | -- | $-17.2M | $-21.6M | $-30.7M | $-28.7M | $-27.2M | $-35.7M | $-42.6M | ||
| Net Income (Discontinued Operations) | $-12.1M | $-19.9M | $-20.8M | $-17.2M | $-21.6M | $-30.7M | $-28.7M | $-27.2M | $-35.7M | $-42.6M | ||
| Net Income (Common Stockholders) | $-12.1M | -- | -- | $-17.2M | $-21.6M | $-30.7M | $-28.7M | $-27.2M | $-35.7M | $-42.6M | ||
| Normalized Income | $-8.9M | $-14.6M | $-15.1M | $-12.6M | $-15.8M | $-22.5M | $-18.3M | $-27.4M | $-35.1M | $-41.9M | ||
| TOTALS | ||||||||||||
| Total Expenses | $-11.6M | -- | -- | -- | $-26.2M | $-37.2M | $36.3M | -- | $43.7M | $57.4M | ||
| SHARE & EPS DATA | ||||||||||||
| Average Shares Outstanding | $415.1K | $6.1M | -- | $11.1M | $17.3M | $20.5M | $20.8M | $21.2M | $24.8M | $30.2M | ||
| Average Shares Outstanding (Diluted) | $415.1K | -- | -- | -- | $17.3M | $20.5M | $20.8M | $21.2M | $24.8M | $30.2M | ||
| Shares Outstanding | $5.5M | $7.3M | $36.3M | $11.9M | $19.6M | $20.8M | $20.3M | $36.3M | $36.3M | $36.3M | ||
| Basic EPS | $-29 | $3.1 | $20.7 | $1.37 | $-1.25 | $-1.5 | $1.38 | $-1.34 | $1.12 | $1.41 | ||
| Basic EPS (Continuing Operations) | $-29 | -- | -- | -- | $-1.25 | $-1.5 | $1.38 | $-1.34 | $1.12 | $1.41 | ||
| Diluted EPS | $-29 | -- | -- | -- | $-1.25 | $-1.5 | $1.38 | $-1.34 | $1.12 | $1.41 | ||
| Diluted EPS (Continuing Operations) | $-29 | -- | -- | -- | $-1.25 | $-1.5 | $1.38 | $-1.34 | $1.12 | $1.41 | ||
| OTHER METRICS | ||||||||||||
| Insurance And Claims | -- | -- | -- | $383.0K | -- | -- | -- | -- | -- | -- | ||
| Other Costof Revenue | -- | -- | -- | -- | -- | -- | $3.7M | $2.9M | $3.6M | $4.7M | ||
| Other Gand A | $3.3M | $5.9M | $16.9M | $5.5M | $7.6M | $10.3M | $9.5M | $18.5M | $23.1M | $32.1M | ||
| Rent And Landing Fees | -- | -- | -- | $270.0K | -- | -- | -- | -- | -- | -- | ||
| Restruct | -- | -- | -- | -- | $90.0K | -- | -- | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PROF | $6.92 | +2.8% | 66.56K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |